NYSE$DGX

Quest Diagnostics Inc · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Quest Diagnostics' financial performance in Q3 2021 decreased slightly compared to the previous year, but the company raised its outlook for the full year due to higher than anticipated COVID-19 testing volumes and base business performance.

Quest Diagnostics reported a slight decrease in revenue and earnings per share for the third quarter of 2021 compared to 2020. However, the company raised its full-year outlook due to higher than anticipated COVID-19 testing volumes and continued solid performance in its base business.

  • Third quarter revenues were $2.77 billion, a 0.4% decrease from 2020.
  • Reported diluted earnings per share (EPS) for the third quarter were $4.02, a 2.8% decrease from 2020; adjusted diluted EPS was $3.96, a 7.9% decrease from 2020.
  • Cash provided by operations year-to-date was $1.75 billion, a 19.6% increase from 2020.
  • The full-year 2021 outlook was raised to reflect higher than anticipated COVID-19 testing volumes and base business performance.

Headline financials

Total Revenue

$2.77B

Previous: $2.79B-0.4%
EPS (adj)

$3.96

Previous: $4.31-8.1%
Revenue per requisition growth

-5.4%

Previous: 20.9%-125.8%
Requisition volume change

5.3%

Previous: 19.7%-73.1%
Organic requisition volume change

3.2%

Previous: 16.6%-80.7%
Capital Expenditures

-$259M

Previous: -$256M-1.2%
Free Cash Flow

$246M

Previous: $312M-21.2%
Net Income

$505M

Previous: $568M-11.1%
Operating Income

$652M

Previous: $718M-9.2%
Gross Profit

$1.1B

Previous: $1.21B-8.5%
Cash & Equivalents

$987M

Previous: $1.61B-38.5%
Total Assets

$13.6B

Previous: $14.1B-4.0%
Stock-Based Comp

$21M

Previous: $32M-34.4%

Revenue & EPS history

Quest Diagnostics · Revenue · Quarterly

$2.77B

Q3 2021-0.4%vs Q3 2020
Beat estimate in 14 of 16 quarters(88%)
ActualEstimate

Revenue by segment

Quest Diagnostics · $2.38B total across 1 segment · Q2 2022

  • Diagnostic information services
    $2.38B

Forward guidance

Quest Diagnostics updated its full year 2021 outlook, projecting net revenues between $10.45 billion and $10.60 billion, reported diluted EPS between $14.69 and $15.09, adjusted diluted EPS between $13.50 and $13.90, cash provided by operations of approximately $2.2 billion, and capital expenditures of approximately $400 million.

Tailwinds

  • Net revenues are projected to be between $10.45 billion and $10.60 billion.
  • Net revenues increase is expected to be between 10.7% and 12.3%.
  • Reported diluted EPS is projected to be between $14.69 and $15.09.
  • Adjusted diluted EPS is projected to be between $13.50 and $13.90.
  • Cash provided by operations is expected to be approximately $2.2 billion.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+0.0%

Avg return

Earnings day

+1.2%

Avg return

5 days after

+2.1%

Avg return

30 days after

45%

33 / 73 earnings

Positive

+11.2%

Q1 2019

Best reaction

-9.9%

Q3 2018

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+4.3%-0.0%-2.2%
Q4 2025+7.4%+8.2%+5.0%
Q3 2025-3.0%-4.3%-1.5%
Q2 2025-0.3%+2.1%+2.2%
Q1 2025+6.8%+7.4%+4.8%
Q4 2024+5.6%+5.1%+11.2%
Q3 2024+6.6%+5.2%+11.2%
Q2 2024-2.3%-1.2%+3.7%
Q1 2024+5.7%+3.2%+7.6%
Q4 2023-2.7%-1.7%-2.9%
Q3 2023+3.3%+5.1%+11.8%
Q2 2023-7.3%-6.7%-8.6%
Q1 2023-5.5%-5.9%-8.9%
Q4 2022-3.9%-1.8%-5.3%
Q3 2022+8.0%+13.7%+15.6%
Q2 2022-2.8%-1.2%+0.5%
Q1 2022-0.9%-2.7%+1.9%
Q4 2021-1.4%-1.0%+1.3%
Q3 2021-0.2%-0.9%+1.1%
Q2 2021+2.7%+3.1%+11.9%
Q1 2021+0.9%+1.8%+1.0%
Q4 2020-4.0%-4.0%-7.0%
Q3 2020+3.5%+3.5%+1.6%
Q2 2020-3.7%-4.9%-9.2%
Q1 2020+6.6%+22.8%+19.4%
Q4 2019+0.0%+0.5%-4.2%
Q3 2019+0.6%-1.6%+2.5%
Q2 2019+5.4%+3.3%+4.6%
Q1 2019+11.2%+11.9%+14.6%
Q4 2018-2.3%-2.0%-1.6%
Q3 2018-9.9%-9.9%-8.2%
Q2 2018-6.3%-7.1%-3.6%
Q1 2018-2.6%-1.0%+1.3%
Q4 2017-2.6%-4.4%-4.1%
Q3 2017+3.3%+3.5%+1.1%
Q2 2017-1.1%+0.1%-2.6%
Q1 2017+5.3%+7.9%+7.9%
Q4 2016+0.9%+0.0%+5.9%
Q3 2016+0.9%+0.2%+3.1%
Q2 2016+1.7%+1.6%+1.6%
Q1 2016+0.8%
Q4 2015-0.1%
Q3 2015-0.3%
Q2 2015+1.2%
Q1 2015-0.6%
Q4 2014+0.7%
Q3 2014+4.2%
Q2 2014+1.4%
Q1 2014-4.2%
Q4 2013-2.5%
Q3 2013-1.4%
Q2 2013-1.3%
Q1 2013-4.4%
Q4 2012-5.5%
Q3 2012-4.5%
Q2 2012-6.8%
Q1 2012-2.4%
Q4 2010+1.0%
Q4 2011+1.0%
Q3 2011+0.4%
Q2 2011-2.1%
Q1 2011+0.2%
Q3 2010+0.1%
Q2 2010+1.7%
Q1 2010-2.6%
Q1 2009-2.6%
Q4 2007+1.8%
Q4 2009+1.8%
Q3 2009-0.1%
Q3 2008-0.1%
Q2 2009-0.6%
Q4 2008-0.6%
Q2 2008-0.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro